返回 Agenda
Session 1: A Flexible Approach to Building Patient Centric Clinical Trials: Navigating the Challenges to Maximize Adoption
Session Chair(s)
Scott Askin, MSC
Global Program Regulatory Director
Novartis Pharma AG, Switzerland
Session 1: A Flexible Approach to Building Patient Centric Clinical Trials: Navigating the Challenges to Maximize Adoption
Speaker(s)
DCT State of Play
Josh Rose, MBA
Hawthorne Effect, United States
Chief Executive Officer
Healthcare Perspective and Challenges
Evelien Rooke
University of Dundee, United Kingdom
Senior Neurology Registrar & Clinical Research Fellow
Patient Perspective and Challenges
Helen Matthews
The Cure Parkinson's Trust, United Kingdom
Deputy CEO
Going Home
Megan Heath, PHD
Sanofi, United Kingdom
Head of Clinical Study Units Europe Region
Panel discussion with Q&A, with the additional participation of:
Isaac R Rodriguez-Chavez, MHS, PHD, MS
4Biosolutions Consulting, United States